Cargando…

Diabetes Modifies the Clinic Presentation of Cutaneous Leishmaniasis

BACKGROUND: Cutaneous leishmaniasis (CL) caused by L. braziliensis is characterized by 1 or multiple well-limited ulcerated lesions. Diabetes mellitus (DM) impairs neutrophil and monocyte function, and there is a report of vegetative lesions in a patient with both diseases in Morocco. Here we evalua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lago, Alexsandro S, Lima, Filipe R, Carvalho, Augusto M, Sampaio, Camilla, Lago, Neuza, Guimarães, Luiz H, Lago, Jamile, Machado, Paulo R L, Carvalho, Lucas P, Arruda, Sérgio, Carvalho, Edgar M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724508/ https://www.ncbi.nlm.nih.gov/pubmed/33324720 http://dx.doi.org/10.1093/ofid/ofaa491

Ejemplares similares

Clinical Profile and Diagnosis of Recurrent Cutaneous Leishmaniasis
por: Arruda, Sérgio, et al.
Publicado: (2023)

Localized skin inflammation during cutaneous leishmaniasis drives a chronic, systemic IFN-γ signature
por: Farias Amorim, Camila, et al.
Publicado: (2021)

Unbalanced production of LTB(4)/PGE(2) driven by diabetes increases susceptibility to cutaneous leishmaniasis
por: Bonyek-Silva, Icaro, et al.
Publicado: (2020)

Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial
por: Lago, Jamile, et al.
Publicado: (2023)

Correction: Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial
por: Lago, Jamile, et al.
Publicado: (2023)

Clinical and histopathologic features of canine tegumentary leishmaniasis and the molecular characterization of Leishmania braziliensis in dogs
por: Lago, Jamile, et al.
Publicado: (2019)

Dogs Harbor Leishmania braziliensis and Participate in the Transmission Cycle of Human Tegumentary Leishmaniasis
por: Lago, Jamile, et al.
Publicado: (2023)

Comparative analysis of the tissue inflammatory response in human cutaneous and disseminated leishmaniasis
por: Dantas, Marina Loyola, et al.
Publicado: (2014)

Development of Cutaneous Leishmaniasis after Leishmania Skin Test
por: Machado, Paulo R., et al.
Publicado: (2011)

Plantar ulcer as an atypical manifestation of cutaneous leishmaniasis()()
por: Tironi, Fernanda de Carvalho, et al.
Publicado: (2021)

Tissue Damage in Human Cutaneous Leishmaniasis: Correlations Between Inflammatory Cells and Molecule Expression
por: Saldanha, Maíra Garcia, et al.
Publicado: (2020)

The miRNA 361-3p, a Regulator of GZMB and TNF Is Associated With Therapeutic Failure and Longer Time Healing of Cutaneous Leishmaniasis Caused by L. (viannia) braziliensis
por: Lago, Tainã S., et al.
Publicado: (2018)

Characterization of the Histopathologic Features in Patients in the Early and Late Phases of Cutaneous Leishmaniasis
por: Saldanha, Maíra G., et al.
Publicado: (2017)

Atypical Manifestations of Cutaneous Leishmaniasis in a Region Endemic for Leishmania braziliensis: Clinical, Immunological and Parasitological Aspects
por: Guimarães, Luiz Henrique, et al.
Publicado: (2016)

“It’s not all about the disease”: do treatment and socioeconomic status affect perceived impact and satisfaction of patients treated for cutaneous leishmaniasis?
por: Carvalho, Carolina Di Pietro, et al.
Publicado: (2023)

A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil
por: Machado, Paulo R L, et al.
Publicado: (2020)

Geographic Clustering of Leishmaniasis in Northeastern Brazil
por: Schriefer, Albert, et al.
Publicado: (2009)

Multi-omic Analyses of Plasma Cytokines, Lipidomics, and Transcriptomics Distinguish Treatment Outcomes in Cutaneous Leishmaniasis
por: Malta-Santos, Hayna, et al.
Publicado: (2020)

Prostaglandin E2 contributes to L. braziliensis survival and therapeutic failure in cutaneous leishmaniasis
por: Nascimento, Maurício T., et al.
Publicado: (2023)

Evaluation of the Ability of Miltefosine Associated with Topical GM-CSF in Modulating the Immune Response of Patients with Cutaneous Leishmaniasis
por: Peixoto, Fábio, et al.
Publicado: (2020)

FLI1 gene influences lesion size and skin test may predict therapeutic response in cutaneous leishmaniasis
por: da Hora, Anadilton Santos, et al.
Publicado: (2020)

Hemophagocytic lymphohistiocytosis secondary to visceral leishmaniasis in an endemic area in the north of Minas Gerais, Brazil
por: de Carvalho, Fernando Henrique Guimarães, et al.
Publicado: (2020)

Estimating direct costs of the treatment for mucosal leishmaniasis in Brazil
por: Carvalho, Janaína de Pina, et al.
Publicado: (2021)

Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil: A Randomized and Controlled Trial
por: Machado, Paulo R., et al.
Publicado: (2010)

Sensitive Molecular Diagnostics for Cutaneous Leishmaniasis
por: Sagi, Orli, et al.
Publicado: (2017)

Blockade of TLR2 and TLR4 Attenuates Inflammatory Response and Parasite Load in Cutaneous Leishmaniasis
por: Carneiro, Pedro Paulo, et al.
Publicado: (2021)

Detection of IgG Anti-Leishmania Antigen by Flow Cytometry as a Diagnostic Test for Cutaneous Leishmaniasis
por: Pedral-Sampaio, Geraldo, et al.
Publicado: (2016)

Dynamics of American tegumentary leishmaniasis in a highly endemic region for Leishmania (Viannia) braziliensis infection in northeast Brazil
por: Silva, Juliana, et al.
Publicado: (2017)

Cytotoxic activity in cutaneous leishmaniasis
por: Campos, Taís M, et al.
Publicado: (2017)

Cutaneous Manifestations of Human and Murine Leishmaniasis
por: Scorza, Breanna M., et al.
Publicado: (2017)

Further insights into the eco-epidemiology of American cutaneous leishmaniasis in the Belem metropolitan region, Pará State, Brazil
por: Gonçalves, Lucas Pantoja, et al.
Publicado: (2020)

Forecasting Temporal Dynamics of Cutaneous Leishmaniasis in Northeast Brazil
por: Lewnard, Joseph A., et al.
Publicado: (2014)

IL-22 Protects against Tissue Damage during Cutaneous Leishmaniasis
por: Gimblet, Ciara, et al.
Publicado: (2015)

Differential effects of antigens from L. braziliensis isolates from disseminated and cutaneous leishmaniasis on in vitro cytokine production
por: Leopoldo, Paulo TG, et al.
Publicado: (2006)

Inhibition of gamma-secretase activity without interfering in Notch signalling decreases inflammatory response in patients with cutaneous leishmaniasis
por: Nascimento, Maurício T., et al.
Publicado: (2021)

NKG2D promotes CD8 T cell-mediated cytotoxicity and is associated with treatment failure in human cutaneous leishmaniasis
por: Sacramento, Laís A., et al.
Publicado: (2023)

Cutaneous parasitism in patients with American visceral leishmaniasis in an endemic area
por: Moura, Carla Riama Lopes de Pádua, et al.
Publicado: (2020)

Clinical and epidemiological profiles of patients with American cutaneous leishmaniasis from the states of Pernambuco and Amazonas, Brazil
por: de Melo, Maria Gabriella Nunes, et al.
Publicado: (2020)

Spatial dynamics and socioeconomic factors correlated with American cutaneous leishmaniasis in Pernambuco, Brazil from 2008 to 2017
por: Gonçalves, Andréa Flávia Luckwü de Santana, et al.
Publicado: (2020)

Schistosoma mansoni rSm29 Antigen Induces a Regulatory Phenotype on Dendritic Cells and Lymphocytes From Patients With Cutaneous Leishmaniasis
por: Lopes, Diego Mota, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_830bmcutl0id0a74qi1osc9r0h